Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk of death by 30%
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
Rising demands and advancements in eye care drive growth
Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections
Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
Subscribe To Our Newsletter & Stay Updated
